RPN2 and neoplasm: After subcutaneous tumor formation for approximately 3 weeks for all groups, TMZ (30 mg kg/day/per mouse) and DMSO (0.3%) treatment every 3 days were further performed to treat one of the two groups (sh-NC and sh-RPN2 group), respectively.